MedPath
NMPA Approval

Teduglutide for Injection

国药准字SJ20240008

February 20, 2024

Drug Information

注射用替度格鲁肽

瑞唯抒

注射剂

5mg/瓶

生物制品

February 20, 2024

February 19, 2029

Company Information

Applicant Company

Block 2 Miesian Plaza, 50 – 58 Baggot Street Lower, Dublin 2, D02 HW68, Ireland

Manufacturing Company

PATHEON ITALIA SPA

Viale G.B. Stucchi, 110, 20900 Monza (MB) Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用替度格鲁肽 - NMPA 批准文号 | MedPath